Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02860702 · ClinicalTrials.gov registry record · NA
Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology
A NA study, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02860702 is a NA study that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 16 participants.
The verdict
NCT02860702, a NA study, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
A randomized, blinded, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet prior to, and throughout the post-operative period following, surgical repair. Human milk is defined as expressed human milk or donor milk and its derivatives, human milk-based fortifier and human milk caloric fortifier. The study hypothesis is that infants fed an exclusive human milk diet will have short and long term benefits, with improved wound healing, growth, and neurodevelopmental outcomes while reducing episodes of feeding intolerance and necrotizing enterocolitis (NEC).
Interventions
- OTHER Human Milk Derived Fortifier
- OTHER Human/Bovine Milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2016-07 |
| Est. Completion | 2022-10-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02860702
The ClinicalTrials.gov registry entry for NCT02860702 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Human Milk Derived Fortifier is the first listed.
NCT02860702 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02860702 about?
NCT02860702 is a clinical study titled "Exclusive Human Milk Feeding in Infants With Single Ventricle Physiology". A randomized, blinded, controlled trial to evaluate growth velocity and clinical outcomes in infants with single ventricle physiology fed an exclusive human milk diet prior to, and throughout the post-operative period following, surgical repair. Human milk is defined as expressed human milk or donor...
What is the current status of trial NCT02860702?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-07. Estimated completion is 2022-10-06.
What interventions are being tested in trial NCT02860702?
The interventions under investigation include: Human Milk Derived Fortifier (OTHER), Human/Bovine Milk (OTHER).
Who is sponsoring clinical trial NCT02860702?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.